aTyr Pharma (LIFE) Tops Q2 EPS by 6c

aTyr Pharma (NASDAQ: LIFE) reported Q2 EPS of ($0.22), $0.06 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c